Full-Time

Security Operations Manager

Information Security, Incident Response

Posted on 9/17/2025

Pattern Bioscience

Pattern Bioscience

51-200 employees

AI-driven rapid bacterial ID and AST

No salary listed

Pune, Maharashtra, India

Hybrid

Hybrid role.

Category
IT & Security (1)
Required Skills
AWS
Requirements
  • Proven experience in leading security operations, incident response, and basic digital forensics.
  • Strong understanding and hands-on experience with SIEM and SOAR platforms.
  • Familiarity with penetration testing methodologies and tools.
  • Experience building and managing an on-call rotation.
  • Familiarity with AWS and cloud security concepts.
  • Excellent written and verbal communication skills and ability to explain technical information to individuals in different departments, including executive leadership.
  • Strong leadership and team management skills.
  • You love learning and staying current with cybersecurity threats and technologies.
  • You love supporting the team more than chasing your personal goals.
Responsibilities
  • Design, implement, and manage a team of incident responders who stay on top of the latest threats to our business.
  • Oversee and participate in the incident response lifecycle, from detection and analysis to containment, eradication, and post-incident review.
  • Manage the endpoint security tooling deployment and tuning.
  • Develop, measure, and continuously improve internal security metrics to assess the effectiveness of security operations and seek improvements.
  • Effectively communicate technical concepts and security strategies to technical teams, executive leadership, and other stakeholders.
  • Execute internal penetration tests and mentor analysts learning how to perform testing. Oversee external penetration testing engagements.
Desired Qualifications
  • Proactively identify and mitigate security risks, showing a strong focus on prevention.
  • Lead incident response efforts efficiently and effectively, minimizing impact.
  • Continuously optimize security operations processes and tools.
  • Follow through with all assignments in a timely manner.
  • Give 100% to all tasks and projects you are given.
  • Actively comment and participate in group collaborations.
  • Focus on delivering results and measuring the impact and implications of outcomes.

Pattern Bioscience develops rapid clinical diagnostics that identify bacterial infections and determine antibiotic resistance. Its system uses single-cell analysis with AI pattern recognition to deliver definitive ID/AST results in about four hours. The product suite includes diagnostic devices, consumables, service contracts, and software for AI analysis. By speeding and improving accuracy, Pattern Bioscience aims to help hospitals reduce inappropriate antibiotic use and combat antibiotic resistance.

Company Size

51-200

Company Stage

Series D

Total Funding

$91.6M

Headquarters

Austin, Texas

Founded

2016

Simplify Jobs

Simplify's Take

What believers are saying

  • $43M Series D funding from AMR Action Fund supports FDA 510(k) submission.
  • $40.9M BARDA contract accelerates pneumonia and bacteremia panel development.
  • Over 1,000 samples enrolled in multi-center trial for Q3 regulatory push.

What critics are saying

  • Accelerate Diagnostics' PhenoVue captures market with FDA-cleared 3-hour AST.
  • BioFire's FilmArray dominates ICU syndromic testing, sidelining single-pathogen focus.
  • Clinical trial failure by mid-2026 exhausts Series D runway, halting launch.

What makes Pattern Bioscience unique

  • Digital CultureTM enables culture-free phenotypic ID/AST in four hours.
  • Single-cell analysis captures all resistance mechanisms unlike genotypic tests.
  • Pneumonia ID/AST Panel targets critically ill patients with FDA Breakthrough Designation.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Unlimited Paid Time Off

Paid Holidays

401(k) Company Match

401(k) Retirement Plan

Health Savings Account/Flexible Spending Account

Growth & Insights and Company News

Headcount

6 month growth

1%

1 year growth

2%

2 year growth

-1%
Legal Desire
Nov 19th, 2025
Pattern Bioscience Raises $43M Series D

Pattern Bioscience has raised $43 million in Series D funding, led by AMR Action Fund, Illumina Ventures, and Omnimed Capital. The funds will support a US multi-center clinical trial and regulatory submission for their Pneumonia ID/AST Panel, which has FDA Breakthrough Device Designation and is backed by a BARDA contract worth up to $40.9 million. Latham & Watkins LLP represented Pattern Bioscience in the transaction.

VCBay
Apr 29th, 2023
Austin-based Biotech startup Pattern Bioscience raises USD 28.7 million in Series C funding

To quickly develop effective treatments for drug-resistant bacterial infections, Pattern is a leader in the application of single-cell microbiology.

Business Wire
Apr 28th, 2023
Pattern Bioscience Secures $28.7 Million in Series C Financing

Pattern Bioscience secures $28.7 million in Series C financing to accelerate development of first-of-its-kind infectious disease diagnostic platform

FinSMEs
Apr 27th, 2023
Pattern Bioscience Raises $28.7M in Series C Financing

Pattern Bioscience, an Austin, TX-based company which specializes in rapid diagnosis and antibiotic susceptibility testing (AST) for bacterial infections, raised $28.7M in Series C funding.

360Dx
Apr 27th, 2023
Pattern Bioscience Closes $28.7M Series C Financing Round | 360Dx

Including the Series C round, Pattern has now raised $68 million to date, the company said in a statement.

INACTIVE